2017 has been an exceptional year for Marinus Pharmaceuticals Inc. (MRNS) as the stock is up an impressive 823% year-to-date, way ahead of the iShares NASDAQ Biotechnology Index (IBB), which has returned just 18% during the same time frame.
from RTT - Biotech http://ift.tt/2C91IXc
via IFTTT
No comments:
Post a Comment